Abstract:BACKGROUND Telomeres are strongly associated with cancer, as their shortening over time is associated with an increased risk of tumor growth and progression. However, the prognostic value of telomere-related genes (TRGs) in breast cancer has not been systematically elucidated. MATERIAL AND METHODS The transcriptome and clinical data of breast cancer were downloaded from TCGA and GEO databases, and prognostic TRGs were identified by differential expression analysis and univariate and multivariate Cox regression analyses. Gene set enrichment analysis (GSEA) of different risk groups was performed. Molecular subtypes of breast cancer were constructed by consensus clustering analysis, and the differences in immune infiltration and chemotherapy sensitivity between subtypes were analyzed. RESULTS Differential expression analysis revealed 86 significantly differentially expressed TRGs in breast cancer, of which 43 were significantly associated with breast cancer prognosis. A predictive risk signature consisting of 6 tumor-related genes (TRGs) was developed, which can accurately stratify patients with breast cancer into 2 distinct groups with significantly different prognoses. Significantly different risk scores were found among different racial groups, treatment groups, and pathological features groups. GSEA results showed that patients in the low-risk group had activated immune responses and repressed cilium-related biological processes. Consistent clustering analysis based on these 6 TRGs obtained 2 molecular models with significant prognosis differences, which revealed distinct immune infiltration and chemotherapy sensitivity. CONCLUSIONS This study conducted a systematic investigation of the expression pattern of TRGs in breast cancer and its prognostic and clustering implications, thereby offering a reference for utilizing it to predict prognosis and evaluate treatment response.

Telomerase Activity in Human Breast Tissues

The Expression of Telomerase Activity in Patients with Non-Small Cell Lung Cancer

Correlation of Pathological Types and Clinical Stages of NSCLC with the Blood Telomerase Activity

Study of Telomerase Activity in Pleural Lavage Fluid Specimens in Patients with Non-Small-cell Lung Cancer and Its Clinical Significance

The Detectin of Telomerase Activity in Non-Small Cell Lung Cancer

Detection of telomerase activity in breast carcinoma

Telomerase Activity of Fibrobronchoscopic Brushing Cells in Non-Small Cell Lung Cancer

[Significance of Telomerase Activity Detection by Fine-Needle Aspiration in Patients with Breast Cancer].

Expression and significance of telomerase in meibomian gland carcinoma

Telomere-Associated Gene Signatures Correlate with Prognosis, Tumor Microenvironment, and Chemosensitivity in Breast Cancer.

[Clinical Implications of Telomerase Activity in Breast Cancer Fine-Needle Aspirates].

Telomerase activity and apoptosis of breast cancer

Telomerase RNA and Telomerase Activity in Trophoblastic Tumors

Blood Telomerase Activity and Its Correlativity with Non-Small Cell Lung Carcinoma

Telomerase Activity and hTRT Gene Expression in Gastric Cancer

THE CLINICAL SIGNIFICANCE OF DETECTING THE TELOMERASE ACTIVITY IN COLORECTAL CANCER

Expression Of Telomeric Repeat Binding Factor 1 Protein In Nonsmall Cell Lung Cancer With Human Telomerase Reverse Transcriptase Positive

Changes of telomerase and telomere lengths in paired normal and cancer tissues of breast.

Telomerase Activity in Bladder Cancer

Expression of telomerase activity in human lung cancer.]

Study on Telomerase Activity in Exfoliated Cells from Humoral Specimens and its Significance